Evidence map›Paper›PMID 40764678›Full record

ArticleNature chemical biology2026

Intracrine FFA4 signaling controls lipolysis at lipid droplets.

Shannon L O'Brien, Emma Tripp, Natasja Barki, Elodie Blondel-Tepaz, Gabrielle Smith, Adam Boufersaoui, Jennie Roberts, Jeremy A Pike, Joao Correia, Tamara Miljus and 7 more

Abstract read
In one paragraph

Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shannon L O'Brien *Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK. s.l.obrien@bham.ac.uk.ORCID 0000-0003-3265-6998
Emma Tripp *Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Natasja BarkiCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Elodie Blondel-TepazDepartment of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Quebec, Canada.
Gabrielle SmithDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Adam BoufersaouiDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Jennie RobertsDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Jeremy A PikeCentre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK.
Joao CorreiaCentre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK.
Tamara MiljusDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID 0000-0003-0462-7866
Michel BouvierDepartment of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0003-1128-0100
Daniel A TennantDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID 0000-0003-0499-2732
Brian D HudsonCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0001-7059-0091
Zachary Gerhart-HinesNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Graeme MilliganCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0002-6946-3519
Thue W SchwartzNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-0261-6904
Davide CalebiroDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK. d.calebiro@bham.ac.uk.ORCID 0000-0002-3811-1553

Funding

Cancer Research UK (CRUK) C17422/A25154Cancer Research UK (CRUK) SEBSTF-2021\100002Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-183758RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/R001480/1RCUK | Medical Research Council (MRC) MR/Z505973/1Wellcome TrustWellcome Trust (Wellcome) 212313/Z/18/Z
6 · The paper itself

Abstract

G-protein-coupled receptors (GPCRs) can signal from intracellular compartments but the occurrence and relevance of this phenomenon for metabolite-sensing GPCRs is largely unknown. Here, we investigate free fatty acid receptor 4 (FFA4), a metabolite-sensing GPCR activated by medium-chain and long-chain fatty acids. Using live-cell imaging, bioluminescence resonance energy transfer, super-resolution microscopy and cell fractionation, we show that FFA4 localizes to intracellular membranes, particularly endoplasmic reticulum subdomains surrounding lipid droplets, in both immortalized adipocytes and mouse adipose tissue. Upon lipolysis, locally released fatty acids appear to rapidly activate this intracellular FFA4 pool, leading to G

Indexed as

Lipid DropletsLipolysisReceptors, G-Protein-CoupledSignal Transduction3T3-L1 CellsAdipocytesAnimalsCyclic AMPHEK293 CellsHumansMiceCyclic AMPFFAR4 protein, mouseReceptors, G-Protein-Coupled

Identifiers

PMID40764678
PMCPMC12727528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.